Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Tex Tex
Feb 09, 2024 8:12AM ET
Oggi la vedo buiaaaa
0
0
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
0.532
-0.018
-3.18%
Type:
Equity
Market:
United States
- Volume: 5,633
- Bid/Ask: 0.000 / 0.000
- Day's Range: 0.520 - 0.540
Luokung Tech
0.532
-0.018
-3.18%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
LKCO Ex Dividend Date, Yield & History
Get details on the Luokung Tech stock dividend history and find the LKCO ex-dividend date. View also the dividend payment date and dividend yield.
No data to display
Write your thoughts about Luokung Technology Corp
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Xi Ying Lim
Dec 21, 2022 8:14AM ET
last chance to buy before head up!!
0
0
Xi Ying Lim
Dec 14, 2022 10:56AM ET
up up up. gogogogo
1
0
Xi Ying Lim
Dec 06, 2022 11:24AM ET
heading up sky rocket soon $1.0
0
0
Nick Povero
Nov 10, 2022 7:06AM ET
Friends partners I have the presumption to say that the base of volumes / price and in communication, the not abundant company is from NASDAQ, so if the managers want to stay in this market they will want their strategies radically in the fence or we will find ourselves further down. Which in itself is not a problem, indeed perhaps a benefit they might know to their value of working with less pressure than and hopefully with collaborators with a deeper definition of intangible asset and cost of production with repeated utility. now. I am also convinced that the business and the ideas they are developing are fascinating, not too much to the deserved satisfaction. My sales target price is 700USD with time horizon 2028.
0
1
Bruno Fattori
Nov 10, 2022 7:06AM ET
ma cosa c@kkio scrivi???????
0
0
Nick Povero
Nov 10, 2022 7:06AM ET
difficulty of having the data (I call it carelessness or little attention to the importance of numbers).
The OTC (it is clear that it should not be seen as a punishment) is more suitable.
Therefore , if we want to stay within this enclosure , we need a radical change in economic communication strategies .
0
0
Nick Povero
Nov 10, 2022 7:06AM ET
Friend Bruno, as a shareholder who believes in the economic activity of this company for the progress it will give to humanity and/or the boost to collective improvement, I believe that the information on social progress is a duty and not an obligation or annoyance. My investment choices are also based on economic data. Accuracy in cost assessment and speed of data publication should characterize this company precisely to make everyone understand what tomorrow will have to be - precision, transparency and timeliness -
I hope you share my critique of R&D cost accounting (see post below) whose valuation process is far too conservative for the revenues these costs will generate in the future.
I am willing to talk to you privately if you wish.
The state of affairs at the date of the post is: quotation below 1, volumes showing little interest, lack of half-yearly data. I also remind you that part of the reasons for the departure of the previous auditors was the difficulty of having the data (I call it carelessness or little attention to the importance of numbers).
The OTC (it is clear that it should not be seen as a punishment) is more suitable.
Therefore , if we want to stay within this enclosure , we need a radical change in economic communication strategies .
0
0
Zane Tam
Oct 05, 2022 10:22AM ET
Soon to be 0.6
2
0
Nick Povero
Sep 08, 2022 9:57AM ET
I am of the opinion that the valuation of the research and development costs of LKCO and its 8 subsidiaries has been carried out in a too rigorous manner, even exceeding the discretion of the valuation processes provided for by the IASB 38.
The discretionary valuation on the useful life of research and development costs should have revolved around the indefinite useful life or definite useful life, but here it appears that this principle has been completely rejected by crudely spending all costs in the year thus negating operating margin and profit for the year.
The reasoning derives from the main activity of the companies, from the company press releases and what is present on the websites that gives certainties about the construction of IT platforms on which to run or sell own or third party services (software), therefore the costs incurred for these platforms and / or software are useful (they generate revenues for several years) for several years and do not run out in the year in which the costs are incurred, therefore their accounting should go under intangible fixed assets and not under operating costs.
Top management and auditors are asked to pay more attention in the valuation processes as the rigorousness required from now on exceeds what IASB 38 indicates.
3
1
my name
Sep 08, 2022 9:57AM ET
absolutely agree
0
0
Magnus Karlsson
Jul 26, 2022 10:15AM ET
What?
0
1
Rabindra Kumar
Feb 14, 2022 12:05PM ET
can i buy every dip?
1
0
Rabindra Kumar
Feb 14, 2022 12:04PM ET
can i buy veery dip?
0
1
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review